Cleared Traditional

K230503 - Polaris X™ Catheter Cable, Blazer™ Dx-20 Catheter Cable (FDA 510(k) Clearance)

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K230503 · Boston Scientific · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2023
Decision
60d
Days
Class 2
Risk

K230503 is an FDA 510(k) clearance for the Polaris X™ Catheter Cable, Blazer™ Dx-20 Catheter Cable. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Boston Scientific (St Paul, US). The FDA issued a Cleared decision on April 25, 2023 after a review of 60 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Scientific devices

Submission Details

510(k) Number K230503 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2023
Decision Date April 25, 2023
Days to Decision 60 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 125d · This submission: 60d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 184
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K230503.
Vision-MR™ Diagnostic Catheter
K252794 · Imricor Medical Systems, Inc. · Jan 2026
MAGiC Sweep™ EP Mapping Catheter
K250590 · Stereotaxis, Inc. · Jul 2025
VIKING™ Fixed Curve Diagnostic Catheter
K250310 · Boston Scientific Corporation · Jun 2025
EP•XT™ Unidirectional Steerable Diagnostic Catheter
K240366 · Boston Scientific Corporation · Nov 2024
Nordica PV Cryo Mapping Catheter
K233900 · Synaptic Medical Corporation · Sep 2024
Cosine-10TM Diagnostic Catheter
K233397 · Medtronic, Inc. · Dec 2023